This inventor holds 1 USPTO granted patent. Top assignee: Neuren Pharmaceuticals Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Douglas Wilson - Innovator in Brain Injury Treatment
Introduction
Douglas Wilson is an esteemed inventor based in Taupo, New Zealand, recognized for his innovative contributions to the field of neurology and brain injury treatment. With a profound commitment to improving patient outcomes, he has secured a patent that addresses a critical medical issue concerning non-convulsive seizures resulting from brain injuries.
Latest Patents
Douglas Wilson holds a patent for the "Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate." This groundbreaking invention focuses on the application of G-2-methyl-prolyl glutamate (G-2MePE) to treat patients suffering from brain injuries, characterized specifically by non-convulsive seizures. The patent emphasizes the effectiveness of G-2MePE in treating various forms of brain injuries, including those caused by traumatic brain injury, stroke, hypoxia/ischemia, and toxic injury.
Career Highlights
Currently, Douglas is affiliated with Neuren Pharmaceuticals Limited, where his dedication to research and innovation drives the company’s mission to deliver novel therapies for neurological disorders. His role at Neuren Pharmaceuticals allows him to collaborate with leading experts in the field and contribute to the advancement of medical science.
Collaborations
Throughout his career, Douglas has had the opportunity to work alongside distinguished colleagues such as Peter David Gluckman and Margaret Anne Brimble. These collaborations reflect a synergy of expertise and a shared vision towards pioneering solutions for neurological health challenges.
Conclusion
Douglas Wilson stands out as an innovator committed to enhancing the lives of patients with brain injuries. His patent on the treatment of non-convulsive seizures is a testament to his dedication and ingenuity in the pursuit of better therapeutic options. As he continues to collaborate with other experts in the field, the potential for further innovations in neurotherapeutics remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile